Next |
home / stock / biib / biib message board
Subject | By | Source | When |
---|---|---|---|
Oops. Another HOD $10 | Lonewolf1 | investorshub | 03/29/2023 1:43:04 PM |
$BIIB Took a little short AH when it's | MiamiGent | investorshub | 03/23/2023 2:13:35 AM |
FDA Accepts Eisai's Filing of a Supplemental Biologics | Mr. Zen | investorshub | 03/06/2023 2:22:27 AM |
This board is about to light up! | Mr. Zen | investorshub | 03/06/2023 2:21:44 AM |
Well Biib and Esaly look to be joined | tredenwater2 | investorshub | 01/09/2023 11:15:02 PM |
Who wants to be the lead Buffalo today? Can | McMagyar | investorshub | 01/09/2023 2:27:14 PM |
Funds swapping spit again, nothing new. | tredenwater2 | investorshub | 01/06/2023 8:54:13 PM |
Imagine if fda had denied? Pyrrhic Victory defined | McMagyar | investorshub | 01/06/2023 8:51:05 PM |
Amen MC. Im surprised at only a 3.5% | tredenwater2 | investorshub | 01/06/2023 8:18:08 PM |
Ps not short Biogen.. Just long dementia | McMagyar | investorshub | 01/06/2023 4:53:22 PM |
Investors can make a difference as to what | McMagyar | investorshub | 01/06/2023 4:46:32 PM |
If you will give a healthy 5 year | McMagyar | investorshub | 01/06/2023 4:42:34 PM |
This will be the last chance to extricate | McMagyar | investorshub | 01/06/2023 2:15:24 PM |
Will Biogen drop like a rock by or | tredenwater2 | investorshub | 01/02/2023 4:25:51 PM |
What a scam! Older article but will take | tredenwater2 | investorshub | 12/12/2022 8:22:51 PM |
Biogen Accused of Baiting Patients With Illegal Drug Co-Pays | tradeherpete | investorshub | 12/11/2022 2:13:15 PM |
RGEN is on a run while Biogen is | Dennisb68 | investorshub | 12/01/2022 9:58:05 PM |
https://www.marketwatch.com/press-release/grabar-law-office-investigates-claims- | jgrabar | investorshub | 12/01/2022 12:38:41 PM |
Unlike the patients heads, the share price swelling | tredenwater2 | investorshub | 11/30/2022 6:20:06 PM |
whytestocks: $BIIB News Article - CrowdStrike (CRWD) Stock Sinks on Weak Guidance | whytestocks | investorshangout | 11/30/2022 4:55:54 PM |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases ...
TOKYO and CAMBRIDGE, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today tha...
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...